Philadelphia, PA – The American Association for Cancer Research (AACR) says it is currently accepting applications for grants designed to help drive research advances in the treatment of bladder cancer, the fourth most commonly diagnosed cancer in men and the eighth in women.
The two-year AACR Henry Shepard Bladder Cancer Research Grants will provide up to US$250,000 in total support for innovative cancer research projects designed to accelerate the discovery, development and application of new agents to treat bladder cancer. In an effort to unify laboratory and clinical work, laboratory-based projects must present plans with clinical collaborations indicating how the work will be translated into the clinic. Similarly, clinical studies must show how the work was derived from basic pre-clinical work and how the results will be channeled back to laboratory-based collaborators. Four grants will be awarded in 2008.
Independent investigators who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may apply. In order to expand the breadth of bladder cancer research, there are no geographical, national or residency status requirements.
For more information on eligibility criteria, the application process and other details about the AACR Henry Shepard Bladder Cancer Research Grants, please visit, www.aacr.org/page14038.aspx. Applications for these grants should be filed electronically through the proposalCENTRAL website at https://proposalcentral.altum.com, Inquiries from investigators regarding this grant should be directed to Hanna Hopfinger at email@example.com. The application deadline is July 25, 2008.